Skip to content

The Effectiveness of Community Re-entry Program (CRP) in Treatment of Schizophrenia

The Effectiveness of Community Re-entry Program On Therapeutic Outcomes in Raazi Psychiatric Center Hospitalized Schizophrenic Patients, in Comparison with Conventional Psychiatric Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180103038207N1
Enrollment
80
Registered
2018-03-04
Start date
2018-02-18
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia disorder (F25.2), Treatment and Rehabilitation.

Interventions

Intervention 1: Intervention group: It consists of 40 patients who, in addition to conventional psychiatric treatment according to hospital routines, are also subject to Community Reentry Program. Th

Sponsors

University of social welfare and rehabilitation sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of schizophrenia based on medical records Age range between 22-60 years Having family Tolerance for group disciplines and inclination for group activities At least a prior hospitalization and passing two years from onset

Exclusion criteria

Exclusion criteria: Comorbidity with personality substance related and addictive disorders Having self management skills

Design outcomes

Primary

MeasureTime frame
Awareness of the nature of disease and drug information, and readiness for discharge. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: community re entry program test.;Ability to design a daily schedule. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: Depending on the ability to complete the daily schedule, the program returns to the community.;Quality of life. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: Short form health questionnaire.;Viscosity. Timepoint: During hospitalization period. Method of measurement: Based on the number of visits to the Nursing Station.;The number of times a venous or muscular injection of psychoactive substance to calm the patient (I.e. PRN). Timepoint: At the end of intervention. Method of measurement: View patient records documentation.;The number of fixation. Timepoint: At the end of intervention. Method of measurement: View patient records documentation.;Positive and negative syndrome. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: Positive and negative syndrome scale.;Inability. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: World Health Organization disability assessment schedule 2.0.;Stigma. Timepoint: At the beginning of the study and after the end of the intervention. Method of measurement: Stigma scale Michael King.;Duration of hospitalization. Timepoint: After inserting the discharge order in the patient file. Method of measurement: View patient records documentation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDavood Arab Ghahestany

University of social welfare and rehabilitation sciences

psychosis@uswr.ac.ir+98 21 3341 6084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026